Home » Topics » Regulatory » Patents

Patents
RSS

Shenzhen Salubris Pharmaceuticals presents new cathepsin K inhibitors

Aug. 13, 2021

B-Raf, MEK1 inhibitors discovered at Chugai

Aug. 13, 2021

Nuvation Bio identifies new adenosine A2a receptor antagonists

Aug. 12, 2021

New PTPN11 inhibitors discovered at Betta Pharmaceuticals

Aug. 12, 2021

Jiangsu Hengrui Medicine and collaborators patent antibacterials

Aug. 12, 2021

Janssen describes mutant FimH compositions

Aug. 12, 2021

Beta Pharma synthesizes new FGFR inhibitors

Aug. 11, 2021

New MAP4K1 inhibitors identified at Blueprint Medicines

Aug. 11, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents BCR-ABL inhibitors

Aug. 11, 2021

New PSMB8 inhibitors divulged by Shouyao Holdings

Aug. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...